tibolone has been researched along with Endometrioma in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullahi, LO; Arena, A; Borghese, G; Degli Esposti, E; Manzara, F; Meriggiola, MC; Moro, E; Raimondo, D; Seracchioli, R; Terzano, P; Zanello, M | 1 |
| Malhas, R; Robinson, L | 1 |
| Hafezi, F; Hafezi, NL; Randleman, JB; Torres-Netto, EA | 1 |
| Chen, J; Cong, J; Gao, H; Jiang, G; Li, Q; Pu, D; Wu, J | 1 |
| Chen, JM; Ding, Y; Gao, HY; Jiang, GH; Li, Q; Wang, Q; Yuan, X | 1 |
| Al Kadri, H; Al-Fozan, HM; Hajeer, A; Hassan, S | 1 |
| Schindler, AE | 1 |
| Brincat, M; Erel, T; Gambacciani, M; Lambrinoudaki, I; Moen, MH; Rees, M; Rozenberg, S; Schenck-Gustafsson, K; Tremollieres, F; Vujovic, S | 1 |
| Lashen, H; Roberts, AL | 1 |
| Choi, D; Kim, MJ; Kim, NY; Lee, DY; Ryoo, U; Yoon, BK | 1 |
| McLaren, JS; Morris, E; Rymer, J | 1 |
| Di Luca, M; Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Venturini, PL | 1 |
| Bae, DS; Choi, DS; Min, JA; Shin, SY; Yoon, BK | 1 |
| Hillard, TC; Soliman, NF | 1 |
| Gornall, RJ; Kerr-Wilson, R; Kinder, RB; McCarthy, K; Sundar, SS; Swingler, GR | 1 |
| Compston, JE; Croucher, PI; Garrahan, NJ; Lindsay, PC; Shaw, RW; Yamaguchi, K | 1 |
| Davies, AP; Oram, D | 1 |
| Bennink, HJ; Kicovic, P; Lindsay, PC; Shaw, RW | 1 |
| Renier, M; Termote, L; Verheyden, B | 1 |
| Buhur, A; Burak, F; Kucuk, S; Taskin, O; Uryan, I; Yalcinoglu, AI | 1 |
| Bell, KL; Compston, JE; Garrahan, N; Lindsay, PC; Loveridge, N; Lunt, M; Reeve, J | 1 |
| Bell, KL; Boyde, A; Compston, JE; Jones, SJ; Loveridge, N; Noble, BS; Reeve, J | 1 |
| Bianchi, S; Fedele, L; Raffaelli, R; Zanconato, G | 1 |
| Moore, RA | 1 |
5 review(s) available for tibolone and Endometrioma
| Article | Year |
|---|---|
Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature.
Topics: Endometriosis; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Retrospective Studies | 2019 |
Hormone therapy for endometriosis and surgical menopause.
Topics: Endometriosis; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause, Premature; Norpregnenes; Pain; Postoperative Complications; Progesterone; Randomized Controlled Trials as Topic; Recurrence | 2009 |
Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update.
Topics: Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Endometriosis; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Leiomyoma; Lipids; Menstruation Disturbances; Norpregnenes; Parathyroid Hormone; Premenstrual Syndrome; Raloxifene Hydrochloride; Uterine Diseases; Vitamin D | 2012 |
Hormone replacement therapy in women with past history of endometriosis.
Topics: Adult; Aged; Endometrial Neoplasms; Endometriosis; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Menopause; Middle Aged; Norpregnenes; Risk Factors | 2006 |
Livial: a review of clinical studies.
Topics: Affective Symptoms; Anabolic Agents; Bone Diseases; Breast Neoplasms; Climacteric; Coronary Disease; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Libido; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Vaginal Diseases | 1999 |
7 trial(s) available for tibolone and Endometrioma
| Article | Year |
|---|---|
Efficacy and safety of remifemin on peri-menopausal symptoms induced by post-operative GnRH-a therapy for endometriosis: a randomized study versus tibolone.
Topics: Adult; Cimicifuga; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Norpregnenes; Perimenopause; Plant Extracts; Prospective Studies | 2014 |
Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study.
Topics: Adult; Double-Blind Method; Drugs, Chinese Herbal; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Norpregnenes; Young Adult | 2015 |
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Image Processing, Computer-Assisted; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies; Rectal Diseases; Treatment Outcome; Triazoles; Triptorelin Pamoate; Ultrasonography; Vaginal Diseases; Vitamins | 2013 |
The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis.
Topics: Adult; Anabolic Agents; Biopsy; Bone Density; Bone Resorption; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ilium; Norpregnenes; Osteoporosis, Postmenopausal; Premenopause; Triptorelin Pamoate | 1995 |
The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
Topics: Adult; Anabolic Agents; Bone Density; Double-Blind Method; Drug Interactions; Endometriosis; Female; Humans; Leiomyoma; Luteolytic Agents; Norpregnenes; Prospective Studies; Triptorelin Pamoate; Uterine Neoplasms | 1996 |
Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis.
Topics: Adult; Anabolic Agents; Double-Blind Method; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Norpregnenes; Osteoporosis; Prospective Studies | 1997 |
Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Anabolic Agents; Endometriosis; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Ovariectomy; Pelvis | 1999 |
12 other study(ies) available for tibolone and Endometrioma
| Article | Year |
|---|---|
Induced menopause in women with endometriosis.
Topics: Age Factors; Endometriosis; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Heart Disease Risk Factors; Humans; Menopause, Premature; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Patient Selection; Quality of Life; Risk Adjustment | 2020 |
Late-onset progression of keratoconus after therapy with selective tissue estrogenic activity regulator.
Topics: Collagen; Corneal Stroma; Corneal Topography; Cross-Linking Reagents; Disease Progression; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Keratoconus; Middle Aged; Norpregnenes; Ovariectomy; Photosensitizing Agents; Riboflavin; Ultraviolet Rays; Visual Acuity | 2019 |
The value of gonadotropin-releasing hormone-agonists together with other drugs for medical treatment and prevention.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Uterine Neoplasms | 2009 |
EMAS position statement: Managing the menopause in women with a past history of endometriosis.
Topics: Endometriosis; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Menopause; Menopause, Premature; Norpregnenes; Recurrence | 2010 |
Tibolone as a hormone replacement in women with endometriosis after bilateral oophorectomy.
Topics: Abdomen; Adult; Chest Pain; Drainage; Endometriosis; Female; Hormone Replacement Therapy; Humans; Norpregnenes; Ovariectomy; Pelvis; Pleural Diseases; Radiography; Treatment Outcome; Triptorelin Pamoate; Ultrasonography | 2010 |
The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis.
Topics: Adult; Cohort Studies; Endometriosis; Endometrium; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Norpregnenes; Pelvic Pain; Ultrasonography | 2011 |
The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with tibolone add-back therapy in endometriosis patients of reproductive age.
Topics: Adult; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Incidence; Norpregnenes; Postoperative Complications; Retrospective Studies; Ultrasonography; Uterine Hemorrhage | 2007 |
A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
Topics: Endometriosis; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Peritoneal Diseases; Recurrence | 2007 |
Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125.
Topics: Antigens, Tumor-Associated, Carbohydrate; Diagnosis, Differential; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Uterine Neoplasms | 1994 |
An unusual coincidence of endometriosis and ovarian stimulation.
Topics: Adult; Anabolic Agents; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility; Norpregnenes; Ovarian Hyperstimulation Syndrome; Ureteral Diseases | 1995 |
Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone.
Topics: Acid Phosphatase; Alkaline Phosphatase; Biomarkers; Biopsy; Bone Density; Bone Remodeling; Drug Therapy, Combination; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ilium; Isoenzymes; Norpregnenes; Osteoclasts; Osteoporosis, Postmenopausal; Software; Tartrate-Resistant Acid Phosphatase; Triptorelin Pamoate | 1997 |
Effect of estrogen suppression on the mineralization density of iliac crest biopsies in young women as assessed by backscattered electron imaging.
Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy; Bone Density; Calcification, Physiologic; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Goserelin; Humans; Ilium; Microscopy, Electron, Scanning; Norpregnenes; Triptorelin Pamoate | 1998 |